Immunic AG | WebDisclosure

Basculer en Français

10091	Companies
206600	Keywords
136786	Articles
109514	Press releases

Home
Companies
Immunic AG

PRESS RELEASE

published on 01/07/2026 at 12:30, 2 months 18 days ago

Immunic Highlights 2025 Accomplishments and Upcoming Milestones
Immunic Inc. highlights its 2025 accomplishments & upcoming milestones including phase 3 trials for Vidofludimus Calcium in relapsing Multiple Sclerosis, positive data in Progressive MS, & potential for IMU-856 in weight management

Immunic Inc. Multiple Sclerosis Vidofludimus Calcium IMU-856 2025 Accomplishments
BRIEF

published on 11/26/2025 at 12:35, 3 months 29 days ago

Immunic participera à la conférence Evercore ISI Healthcare en décembre

Biotechnologie Conférence Sur Les Soins De Santé Immunitaire Maladies Neurologiques Réunions Avec Les Investisseurs
BRIEF

published on 11/26/2025 at 12:35, 3 months 29 days ago

Immunic to Join Evercore ISI Healthcare Conference in December

Biotechnology Immunic Investor Meetings Healthcare Conference Neurologic Diseases
PRESS RELEASE

published on 11/26/2025 at 12:30, 3 months 29 days ago

Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
Immunic to participate in the 8th Annual Evercore ISI Healthcare Conference in December. Dr. Daniel Vitt to speak at fireside chat on novel oral therapies for neurologic and gastrointestinal diseases

Gastrointestinal Diseases Immunic Neurologic Diseases Evercore ISI Healthcare Conference Daniel Vitt
BRIEF

published on 11/13/2025 at 12:35, 4 months 12 days ago

Immunic, Inc. annonce ses résultats financiers et ses mises à jour pour le troisième trimestre 2025

Résultats Financiers Essais Cliniques Sclérose En Plaques Vidofludimus Calcium Immunique, Inc.
BRIEF

published on 11/13/2025 at 12:35, 4 months 12 days ago

Immunic, Inc. Announces Third Quarter 2025 Financial Results and Updates

Financial Results Clinical Trials Immunic, Inc. Multiple Sclerosis Vidofludimus Calcium
PRESS RELEASE

published on 11/13/2025 at 12:30, 4 months 12 days ago

Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Immunic, Inc. reports Q3 2025 financial results and provides corporate update, highlighting vidofludimus calcium's therapeutic potential in multiple sclerosis. Phase 3 ENSURE trial data expected by 2026

Financial Results Immunic Inc. Vidofludimus Calcium Phase 3 Trials MS Therapy
BRIEF

published on 10/29/2025 at 11:35, 4 months 27 days ago

Immunic to Participate in Key November Conferences

Biotechnology Immunic Conference Participation BIO-Europe Jefferies Conference
BRIEF

published on 10/29/2025 at 11:35, 4 months 27 days ago

Immunisé pour participer aux principales conférences de novembre

Biotechnologie Conférence Jefferies Participation À La Conférence BIO-Europe Immunique
PRESS RELEASE

published on 10/29/2025 at 11:30, 4 months 27 days ago

Immunic to Participate in Industry and Investor Conferences in November
Immunic, Inc. to participate in industry and investor conferences in November, presenting clinical pipeline of therapies for inflammatory diseases

Investor Conferences Immunic Inc. Clinical Pipeline Inflammatory Diseases Industry Conferences

Accesswire

Published on 03/26/2026 at 08:05, 40 minutes ago

Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 3 hours 50 minutes ago

Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 8 hours 5 minutes ago

Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 8 hours 15 minutes ago

Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 13 hours 30 minutes ago

Gemina Laboratories Ltd. Announces Delisting from the CSE

View all ACCESSWIRE

EQS Group

Published on 03/26/2026 at 08:20, 25 minutes ago

Eurobattery Minerals initiates comprehensive metallurgical testwork with SLR for the San Juan tungsten project
Published on 03/26/2026 at 08:00, 44 minutes ago

PNE AG closes the 2025 financial year with successful operational performance and focuses on core markets and profitability
Published on 03/26/2026 at 08:00, 45 minutes ago

Appointment and Retirement of Non-Executive Directors
Published on 03/26/2026 at 08:00, 45 minutes ago

CANCOM SE: CANCOM confirms preliminary figures; 2026 forecast published
Published on 03/26/2026 at 08:00, 45 minutes ago

LPKF reports slight improvement in earnings in 2025 and initiates Group realignment

Les Echos

Published on 03/26/2026 at 07:30, 1 hour 15 minutes ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 1 hour 15 minutes ago

BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 13 hours 51 minutes ago

CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
Published on 03/25/2026 at 18:53, 13 hours 52 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 14 hours 14 minutes ago

Strong investment performance and active roll-out of our strategy

View all LES ECHOS COMFI WIRE